Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1541
-
1542
4-Hz rhythmicity of spiking activity decreases after medial septum inactivation.
Published 2023“…<p>(A) Color-coded autocorrelograms of interneurons (left) and pyramidal cells (right) during maze runs (upper), and during wheel runs before (middle) and after muscimol injection (lower). …”
-
1543
-
1544
-
1545
-
1546
-
1547
-
1548
The numbers of mature T cells from transgenic mice bearing mutated CD3ε were decreased, and they were actively proliferating in a homeostatic manner.
Published 2009“…Fold decreases for the two populations are indicated. Data shown are for 8 tgε<sup>Mut</sup> mice and 13 wt control mice (4 BL6, 1 tgε<sup>WT</sup>cd3ε<sup>+/−</sup>, 5 tgε<sup>Mut</sup>cd3ε<sup>+/−</sup>, and 3 tgε<sup>WT</sup>). …”
-
1549
Structure of YOLOv5s-SBC.
Published 2024“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
-
1550
-
1551
-
1552
-
1553
-
1554
-
1555
-
1556
-
1557
T0 treatment significantly decreased soluble Aβ oligomers, but not amyloid plaque pathology in APP/E4/Abca1<sup>+/-</sup> mice.
Published 2017“…N = 5–6 mice per group. N.S., not significant. <b>E,</b> T0 treatment significantly decreases Aβ oligomers in APP/E4/Abca1<sup>+/-</sup> mice. …”
-
1558
A summary of the included study characteristics.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
1559
-
1560